| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $11,185,793 ) |
| | 2024 | 2024 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R25HL121037 | Promoting Underrepresented Minority Advancement in the Sciences (PUMAS) | 000 | 11 | NIH | 4/12/2024 | $166,320 |
| | 2024 | 2024 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | F32HD114427 | Transcriptional variation in human milk | 000 | 1 | NIH | 12/15/2023 | $69,080 |
| | 2024 | 2024 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R01AG085468 | Study Alzheimer's Disease Protective APOE Variants | 000 | 1 | NIH | 12/14/2023 | $941,364 |
| | 2024 | 2024 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R01AI183286 | Targeting the transcriptionally-active reservoir to reduce chronic inflammation in aged people with HIV | 000 | 1 | NIH | 2/26/2024 | $915,998 |
| | 2024 | 2024 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R01AI180651 | Targeting Feedback Circuitry for Antiviral Therapy | 000 | 1 | NIH | 12/11/2023 | $850,489 |
| | 2024 | 2024 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | F32AG085961 | Investigation into transcriptomic control of dentate granule cell maturation and hyperexcitability in the apoE4 Alzheimer's Disease model | 002 | 1 | NIH | 1/30/2024 | $0 |
| | 2024 | 2024 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | F32AG085961 | Investigation into transcriptomic control of dentate granule cell maturation and hyperexcitability in the apoE4 Alzheimer's Disease model | 000 | 1 | NIH | 11/8/2023 | $69,500 |
| | 2024 | 2024 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | F32AG085961 | Investigation into transcriptomic control of dentate granule cell maturation and hyperexcitability in the apoE4 Alzheimer's Disease model | 001 | 1 | NIH | 11/8/2023 | $0 |
| | 2024 | 2024 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R13NS137704 | American Society for Neural Therapy and Repair Annual Conference | 000 | 1 | NIH | 3/25/2024 | $25,000 |
| | 2024 | 2024 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R01CA276368 | Decoding and reprogramming T cells through synthetic biology for cancer immunotherapy | 001 | 2 | NIH | 4/19/2024 | $37,462 |
| | 2024 | 2024 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R01CA276368 | Decoding and reprogramming T cells through synthetic biology for cancer immunotherapy | 000 | 2 | NIH | 12/6/2023 | $674,325 |
| | 2024 | 2024 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | F32NS127998 | Deconstructing epileptic circuits in a mouse model of SLC6A1 syndrome | 000 | 2 | NIH | 2/12/2024 | $70,052 |
| | 2024 | 2024 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R01LM013617 | Image Tools for Computational Cellular Barcoding and Automated Annotation | 000 | 3 | NIH | 12/21/2023 | $358,515 |
| | 2024 | 2024 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R01NS121287 | Role of Myeloid And CD4+ T Immune Cells in Post-Traumatic Plasticity | 002 | 3 | NIH | 1/29/2024 | $71,820 |
| | 2024 | 2024 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R01NS121287 | Role of Myeloid And CD4+ T Immune Cells in Post-Traumatic Plasticity | 001 | 3 | NIH | 1/26/2024 | $71,820 |
| | 2024 | 2024 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R01NS121287 | Role of Myeloid And CD4+ T Immune Cells in Post-Traumatic Plasticity | 000 | 3 | NIH | 11/28/2023 | $371,162 |
| | 2024 | 2024 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R01NS121287 | Role of Myeloid And CD4+ T Immune Cells in Post-Traumatic Plasticity | 003 | 3 | NIH | 4/23/2024 | $28,867 |
| | 2024 | 2024 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R37AI109593 | Modulating Stochastic Gene Expression for Cell-fate Control and Therapeutics | 000 | 9 | NIH | 3/5/2024 | $826,602 |
| | 2024 | 2024 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R37AI109593 | Modulating Stochastic Gene Expression for Cell-fate Control and Therapeutics | 001 | 9 | NIH | 3/7/2024 | $95,634 |
| | 2024 | 2024 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R01HL155906 | Gene regulatory networks for heart development | 000 | 4 | NIH | 1/3/2024 | $540,091 |
| | 2024 | 2024 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R01AG065428 | Defining Strategies to Target Energy Failure in Metabolically Vulnerable Human Cells | 000 | 5 | NIH | 4/22/2024 | $620,722 |
| | 2024 | 2024 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | DP1DA051144 | A Gene Drive Therapy for HIV: single-administration intervention for high-risk groups | 000 | 5 | NIH | 3/5/2024 | $850,500 |
| | 2024 | 2024 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R01AG064579 | Cell and Network Disruptions and Associated Pathogenenesis in Tauopathy and Down Syndrome | 000 | 5 | NIH | 4/18/2024 | $641,436 |
| | 2024 | 2024 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R01AG065540 | Study the Protective Roles of ApoE2 in Alzheimer's Disease Using Reprogrammed Isogenic Cells | 000 | 5 | NIH | 4/18/2024 | $724,286 |
| | 2024 | 2024 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R01DK123746 | Modeling intestinal dysfunction in HIV infection with organoid technology | 000 | 5 | NIH | 12/20/2023 | $710,788 |
| | 2024 | 2024 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R37AI083139 | Role of Factor Acetylation in the Regulation of HIV Transcription | 000 | 15 | NIH | 4/1/2024 | $737,100 |
| | 2024 | 2024 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R21HL173710 | Targeted Delivery of Cas9 to Lung Epithelial Cells using Enveloped Delivery Vehicles | 000 | 1 | NIH | 3/27/2024 | $236,250 |
| | 2024 | 2024 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R01HL114948 | Early Cardiac Progenitors | 000 | 12 | NIH | 3/1/2024 | $508,395 |
| | 2024 | 2023 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | K99NS126707 | Epigenomic regulation of oxidative stress-producing innate immunity in neuroinflammation | 001 | 2 | NIH | 4/4/2024 | $0 |
| | 2024 | 2023 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | K99NS126707 | Epigenomic regulation of oxidative stress-producing innate immunity in neuroinflammation | 000 | 2 | NIH | 2/8/2024 | $0 |
| | 2024 | 2023 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | U01HL157989 | Genetic determinants of 4D genome folding in human cardiac development | 000 | 4 | NIH | 4/6/2024 | $0 |
| | 2024 | 2023 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | K02NS110973 | Fibrinogen-mediated mechanisms of preterm infant brain injury | 000 | 4 | NIH | 1/8/2024 | $0 |
| | 2024 | 2023 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R25HL121037 | Promoting Underrepresented Minority Advancement in the Sciences (PUMAS) | 001 | 10 | NIH | 4/14/2024 | $0 |
| | 2024 | 2022 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | F32NS119348 | Engineering Human Interneurons for Neural Repair | 000 | 2 | NIH | 10/31/2023 | $0 |
| | 2024 | 2022 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R21AI156915 | Targeting Tat/TAR interactions with the superelongation complex to develop novel treatments for HIV/AIDS | 000 | 2 | NIH | 2/22/2024 | $0 |
| | 2024 | 2022 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R00AG059918 | Functional characterization of the Alzheimer's disease Epigenome | 000 | 5 | NIH | 1/11/2024 | $0 |
| | 2024 | 2022 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | U01ES032673 | JAX-Gladstone, SCGE Disease Models Studies Supplement | 001 | 5 | NIH | 4/18/2024 | -$6,035 |
| | 2024 | 2022 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | U01ES032673 | JAX-Gladstone, SCGE Disease Models Studies Supplement | 000 | 5 | NIH | 4/18/2024 | -$21,750 |
| | 2024 | 2021 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | RF1AG062234 | Optogenetic dissection of cellular and circuit mechanisms of network dysfunction and amyloid deposition in mouse models of Alzheimer's disease in vivo | 000 | 1 | NIH | 2/20/2024 | $0 |
| | 2024 | 2021 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R01DA044605 | Assessing the root causes of chronic inflammation in HIV-infected individuals using drugs of abuse | 000 | 5 | NIH | 1/25/2024 | $0 |
| | 2024 | 2020 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | K99AG062776 | Functional Alterations of Parvalbumin Interneurons Contributing to Abnormal Network Activity in Alzheimer's Disease Mouse Models | 000 | 2 | NIH | 1/22/2024 | $0 |
| | 2024 | 2019 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | RF1AG064926 | Fibrinogen and vascular cognitive impairment: mechanisms, imaging, therapeutics | 000 | 1 | NIH | 1/12/2024 | $0 |
| | 2024 | 2019 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | RF1AG064170 | Understand and probing disrupted glucose metabolism in Alzheimer's disease | 000 | 1 | NIH | 1/10/2024 | $0 |
| | 2024 | 2019 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | RF1AG059751 | Proteomic and Genetic Approaches Defining Apolipoprotein E4 Neuropathologic Mechanisms | 000 | 1 | NIH | 1/10/2024 | $0 |
| | 2024 | 2019 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | RF1AG063519 | Neural network and immune cell dysfunctions in Alzheimer's disease pathogenesis | 000 | 1 | NIH | 1/10/2024 | $0 |
| | 2024 | 2019 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | RF1AG060765 | Novel Therapeutic Approaches to Increase Progranulin Levels in Brain to Treat FTD and AD | 000 | 1 | NIH | 1/12/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $40,364,957 ) (Continued on the next page) |
| | 2023 | 2023 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | K02NS110973 | Fibrinogen-mediated mechanisms of preterm infant brain injury | 000 | 4 | NIH | 1/5/2023 | $150,059 |
| | 2023 | 2023 | J.DAVID GLADSTONE INSTITUTES | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | K02NS110973 | Fibrinogen-mediated mechanisms of preterm infant brain injury | 001 | 4 | NIH | 2/9/2023 | -$4,000 |
|
